{"id":94183,"date":"2025-07-26T13:30:09","date_gmt":"2025-07-26T13:30:09","guid":{"rendered":"https:\/\/www.europesays.com\/us\/94183\/"},"modified":"2025-07-26T13:30:09","modified_gmt":"2025-07-26T13:30:09","slug":"lawmakers-press-fda-to-target-knockoff-weight-loss-drugs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/94183\/","title":{"rendered":"Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs"},"content":{"rendered":"<p class=\"media-ui-Paragraph_text-SqIsdNjh0t0-\" data-component=\"paragraph\">Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. <\/p>\n<p class=\"media-ui-Paragraph_text-SqIsdNjh0t0-\" data-component=\"paragraph\">On Friday, a group of more than 80 bipartisan lawmakers asked the <a href=\"https:\/\/www.bloomberg.com\/quote\/3400398Z:US\" target=\"_blank\" rel=\"noopener\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">US Food and Drug Administration<\/a> to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market \u2014 a problem that emerged over the last year.<\/p>\n","protected":false},"excerpt":{"rendered":"Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss&hellip;\n","protected":false},"author":3,"featured_media":94184,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[1230,62222,6434,210,62220,62224,61450,1060,401,519,62221,3229,62223,67,132,68],"class_list":{"0":"post-94183","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-drugs","9":"tag-eli-lilly-co","10":"tag-food-and-drug-administration","11":"tag-health","12":"tag-hims-hers-health-inc","13":"tag-industries","14":"tag-july-sarl-caen","15":"tag-medication","16":"tag-new-jersey","17":"tag-north-carolina","18":"tag-novo-nordisk-a-s-b","19":"tag-regulation","20":"tag-telemedicine","21":"tag-united-states","22":"tag-unitedstates","23":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114919782695331660","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/94183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=94183"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/94183\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/94184"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=94183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=94183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=94183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}